“…Currently, the commonly used staging systems like BCLC stage and Tumor-Node-Metastasis (TNM) staging system of the American Joint Committee on Cancer (AJCC) primarily consider factors such as tumor size, number, and MVI. 24,26 Because the postoperative recurrence of HCC is influenced by numerous factors, including nutritional and immune status, portal hypertension, HBV DNA load, Edmondson-Steiner grade, satellite nodules, etc; 18,[27][28][29][30] the ability to perform individualized assessments of patients using the common staging systems is limited. Previous prognostic models mainly focused on tumor-related variables and did not consider other conditions, such as the nutritional and immune status of the patients or liver cirrhosis.…”